Startups
Sensorium Therapeutics
Sensorium Therapeutics is a clinical-stage biotechnology company developing small-molecule medicines for central nervous system disorders. Its SensAI discovery platform combines artificial intelligence, natural-product chemistry, pharmacology and neuroscience to identify therapeutic candidates. Its pipeline includes programs for anxiety, drug-resistant epilepsy and cognitive impairment associated with neurodegenerative disease.
Team
Alan F. SchatzbergScientific and Clinical Advisor |
Alex SimonChief of Staff |
Andrew CutlerScientific and Clinical Advisor |
Charles B. NemeroffScientific and Clinical Advisor |
Charles GreenScientific and Clinical Advisor |
Chaya D. PatelBoard Member |
Colville BrownChief Medical Officer |
Dick SimonCo-Founder and Board Member |
Douglas FeltnerScientific and Clinical Advisor |
Evan GibsonChief Business Officer |
Jacob HookerCo-Founder, President, Chief Executive Officer and Board Member |
Jeffrey StrawnScientific and Clinical Advisor |
Jerrold RosenbaumCo-Founder and Board Member |
 K. Ranga KrishnanScientific and Clinical Advisor |
 Kevin LalandeBoard Member |
Kseniya SimpsonBoard Observer |
 Maurizio FavaScientific and Clinical Advisor |
Murray B SteinScientific and Clinical Advisor |
 Raymond SanchezScientific and Clinical Advisor |
Ryan KatzBoard Member |
Sanjay J. MathewScientific and Clinical Advisor |
Simba GillExecutive Chairman |
Stephen HaggartyCo-Founder |